Amplifon (AMFPF) Stock Price, News & Analysis

Company Overview

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. It also operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A.

Key Stats

• Today's Range: $17.46 to $17.46
• 50-Day Range: $17.17 to $23.85
• 52-Week Range: $16.97 to $29.33
• Volume: N/A
• Average Volume: 2,678 shs
• Market Capitalization: $3.94 billion
• P/E Ratio: 28.62
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Moderate Buy

AMFPF Stock Analysis - Frequently Asked Questions

How have AMFPF shares performed this year?

Amplifon's stock was trading at $26.0025 at the beginning of the year. Since then, AMFPF stock has decreased by 32.9% and is now trading at $17.46.

How were Amplifon's earnings last quarter?

Amplifon S.p.A. (OTCMKTS:AMFPF) announced its earnings results on Thursday, August, 7th. The company reported $0.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by $0.09. The business had revenue of $698.20 million for the quarter, compared to the consensus estimate of $625.73 million. Amplifon had a net margin of 5.20% and a trailing twelve-month return on equity of 13.49%.

How do I buy shares of Amplifon?

Shares of AMFPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/07/2025
• Today: 8/09/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:AMFPF
• CIK: N/A
• Web: corporate.amplifon.com
• Phone: (390) 257-4721
• Fax: N/A
• Employees: 15,070
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.61
• Trailing P/E Ratio: 28.62
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $157.31 million
• Net Margins: 5.20%
• Pretax Margin: 8.17%
• Return on Equity: 13.49%
• Return on Assets: 3.88%

Debt

• Debt-to-Equity Ratio: 0.85
• Current Ratio: 0.62
• Quick Ratio: 0.54

Sales & Book Value

• Annual Sales: $2.61 billion
• Price / Sales: 1.51
• Cash Flow: $2.19 per share
• Price / Cash Flow: 7.98
• Book Value: $5.52 per share
• Price / Book: 3.16

Miscellaneous

• Outstanding Shares: 225,500,000
• Free Float: N/A
• Market Cap: $3.94 billion
• Optionable: Not Optionable
• Beta: 0.53